These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3655470)

  • 1. Method for detecting sulfones in urine.
    Jaled MM; De Carli EI; Fariña MH; Gatti JC
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):560-1. PubMed ID: 3655470
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi centre evaluation of "DDS tile test" for detection of dapsone in urine.
    Naik SS; Ganapati R
    Indian J Lepr; 1989 Apr; 61(2):301-2. PubMed ID: 2664019
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of a urine spot test and blood tests as indicators of patient compliance.
    Yoder LJ; Guitrau M; Jacobson R
    Indian J Lepr; 1991; 63(2):195-202. PubMed ID: 1783788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ELISA inhibition technique for the demonstration of sulphones in body fluids. II. A new method to monitor leprosy patient compliance under field conditions.
    Huikeshoven H; de Wit M; Soeters A; Landheer J; Leiker DL
    Lepr Rev; 1981 Mar; 52(1):11-8. PubMed ID: 7017317
    [No Abstract]   [Full Text] [Related]  

  • 5. Do leprosy patients in Papua New Guinea take their dapsone?
    Ree GH; Taylor VE
    P N G Med J; 1979; 22(2):145-7. PubMed ID: 399578
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient compliance with dapsone administration in leprosy.
    Huikeshoven H
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):228-58. PubMed ID: 7024150
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug compliance among self-motivated leprosy patients.
    Girdhar A; Mishra B; Bagga A; Girdhar BK
    Indian J Lepr; 1988 Oct; 60(4):506-9. PubMed ID: 3253330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of "tile reaction" test for screening dapsone in urine.
    Irudaya Raj PP; Lilly L; Aschhoff M; Balakrishnan S
    Lepr India; 1983 Oct; 55(4):654-64. PubMed ID: 6668921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorimetric screening of dapsone in urine for drug trials.
    Balakrishnan S
    Lepr India; 1980 Apr; 52(2):245-8. PubMed ID: 7005540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple urine spot test for monitoring dapsone self-administration in leprosy treatment.
    Huikeshoven H
    Bull World Health Organ; 1986; 64(2):279-81. PubMed ID: 3488843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encouraging results from DDS urine analysis among registered leprosy patients in Wangas, Kenya: an exception that challenges the rule.
    Huikeshoven H; Bijleveld I
    Lepr Rev; 1978 Mar; 49(1):47-52. PubMed ID: 642686
    [No Abstract]   [Full Text] [Related]  

  • 12. Tile test to monitor the self administration of dapsone by leprosy patients.
    Naik SS
    Lepr India; 1983 Oct; 55(4):665-9. PubMed ID: 6668922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spot test for detection of dapsone in urine: an assessment of its validity and interpretation in monitoring dapsone self-administration.
    Huikeshoven H; Madarang MG
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):21-4. PubMed ID: 3711714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of self administration of dapsone in urine by out-patients attending field clinics.
    Balakrishnan S; Christian M
    Lepr India; 1980 Apr; 52(2):249-51. PubMed ID: 7453139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative value of Dapsone "spot test" and Dapsone "tile test" in leprosy control programme.
    Naik SS
    Indian J Lepr; 1984; 56(4):847-51. PubMed ID: 6549456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of HI test for dapsone in urine under field conditions.
    de Wit M; Balakrishnan S; Kumar A
    Indian J Lepr; 1985; 57(2):318-22. PubMed ID: 4078357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring self administration of dapsone by patients.
    Balakrishnan S
    Lepr India; 1977 Jul; 49(3):364-71. PubMed ID: 592739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving patient compliance--a multicentre evaluation of the 'DDS tile test'.
    Naik SS; Vartak RR; Sequiera EB
    Indian J Lepr; 1994; 66(4):473-5. PubMed ID: 7714357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of a dapsone compliance program in leprosy.
    Piscitelli SC; Danziger LH; Hill C; Slajchert AA; West DP; Fischer JH
    Int J Dermatol; 1993 Mar; 32(3):206-9. PubMed ID: 8444536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine tests to monitor the self-administration of dapsone by leprosy patients.
    Ellard GA; Gammon PT; Helmy HS; Rees RJ
    Am J Trop Med Hyg; 1974 May; 23(3):464-70. PubMed ID: 4823797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.